688319 歐林生物
按盤價 
11.010 +0.240 (+2.228%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.440 | 1.952 | 3.079 | 17.675 | 10.070 |
| 總資產報酬率 ROA (%) | 0.243 | 1.136 | 1.975 | 11.652 | 6.399 |
| 投入資產回報率 ROIC (%) | 0.328 | 1.602 | 2.763 | 16.560 | 7.888 | 邊際利潤分析 |
| 銷售毛利率 (%) | 94.717 | 93.550 | 92.865 | 93.927 | 95.140 |
| 營業利潤率 (%) | 0.134 | 0.625 | 7.601 | 20.852 | 10.349 |
| 息稅前利潤/營業總收入 (%) | 2.825 | 4.091 | 8.212 | 21.991 | 11.477 |
| 淨利潤/營業總收入 (%) | -0.021 | 2.306 | 4.854 | 22.162 | 11.287 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 472.052 | 33.731 | 67.609 | 94.906 | 97.241 |
| 價值變動淨收益/利潤總額(%) | 34.591 | 6.671 | 8.478 | 3.512 | 0.595 |
| 營業外收支淨額/利潤總額(%) | 64.074 | 80.159 | 4.656 | 5.231 | 8.309 | 償債能力分析 |
| 流動比率 (X) | 1.860 | 1.955 | 1.782 | 2.561 | 1.513 |
| 速動比率 (X) | 1.673 | 1.804 | 1.632 | 2.343 | 1.321 |
| 資產負債率 (%) | 46.067 | 42.282 | 39.694 | 30.302 | 41.214 |
| 帶息債務/全部投入資本 (%) | 27.352 | 18.658 | 11.303 | 2.665 | -- |
| 股東權益/帶息債務 (%) | 257.455 | 422.883 | 757.413 | 3,545.245 | 4,472.123 |
| 股東權益/負債合計 (%) | 115.836 | 134.475 | 150.186 | 230.013 | 142.637 |
| 利息保障倍數 (X) | 1.153 | 4.335 | 34.304 | -1,787.579 | 60.488 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 356.015 | 356.438 | 272.293 | 194.981 | 0.000 |
| 存貨周轉天數 (天) | 1,074.426 | 847.387 | 705.108 | 733.200 | 0.000 |
| 備註： | 即時報價更新時間為 08/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
